Antibody-Mediated Rejection Criteria – an Addition to the Banff '97 Classification of Renal Allograft Rejection Export

@article{citeulike:5397054, abstract = {Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.}, address = {The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Massachusetts General Hospital, Boston, MA, USA; The University of Alberta, Edmonton, Alberta, Canada; The University of Basel, Basel, Switzerland; University of California, Los Angeles, CA, USA; Catholic University of Louvain Medical School, Brussels, Belgium; University of Pittsburg, Pittsburgh, PA, USA; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Vanderbilt University, Nashville, TN, USA; University of Leicester, Leicester, UK; Health Sciences Center, Winnipeg, Manitoba, Canada ; Hpital Europen Georges Pompidou, Paris, France; University of Helsinki, Helsinki, Finland; University of Iowa, Iowa City, Iowa, USA; Yale University, New Haven, CT, USA; University of Texas, Houston, TX, USA; St. Pauls Hospital, Vancouver, British Columbia, Canada; Nagoya City University, Nagoya, Japan; University of North Carolina, Chapel Hill, NC, USA; University of Vienna, Vienna, Austria; University of Barcelona, Barcelona, Spain; Cornell Medical Center, New York, NY, USA; National Hospital, Oslo, Norway; Rockyview General Hospital, Calgary, Alberta, Canada}, author = {Racusen, Lorraine C. and Colvin, Robert B. and Solez, Kim and Mihatsch, Michael J. and Halloran, Philip F. and Campbell, Patricia M. and Cecka, Michael J. and Cosyns, Jean-Pierre and Demetris, Anthony J. and Fishbein, Michael C. and Fogo, Agnes and Furness, Peter and Gibson, Ian W. and Glotz, Denis and Hayry, Pekka and Hunsickern, Lawrence and Kashgarian, Michael and Kerman, Ronald and Magil, Alex J. and Montgomery, Robert and Morozumi, Kunio and Nickeleit, Volker and Randhawa, Parmjeet and Regele, Heinz and Seron, Daniel and Seshan, Surya and Sund, Stale and Trpkov, Kiril}, citeulike-article-id = {5397054}, citeulike-linkout-0 = {http://dx.doi.org/10.1034/j.1600-6143.2003.00072.x}, citeulike-linkout-1 = {http://www3.interscience.wiley.com/cgi-bin/abstract/118901775/ABSTRACT}, doi = {10.1034/j.1600-6143.2003.00072.x}, issn = {1600-6143}, journal = {American Journal of Transplantation}, keywords = {banff, transplant}, number = {6}, pages = {708--714}, posted-at = {2009-08-08 09:48:55}, priority = {2}, title = {Antibody-Mediated Rejection Criteria \&\#x2013; an Addition to the Banff '97 Classification of Renal Allograft Rejection}, url = {http://dx.doi.org/10.1034/j.1600-6143.2003.00072.x}, volume = {3}, year = {2003} }

TY - JOUR ID - citeulike:5397054 L3 - citeulike-article-id:5397054 N2 - Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation. IS - 6 JF - American Journal of Transplantation SN - 1600-6143 AD - The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Massachusetts General Hospital, Boston, MA, USA; The University of Alberta, Edmonton, Alberta, Canada; The University of Basel, Basel, Switzerland; University of California, Los Angeles, CA, USA; Catholic University of Louvain Medical School, Brussels, Belgium; University of Pittsburg, Pittsburgh, PA, USA; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Vanderbilt University, Nashville, TN, USA; University of Leicester, Leicester, UK; Health Sciences Center, Winnipeg, Manitoba, Canada ; Hpital Europen Georges Pompidou, Paris, France; University of Helsinki, Helsinki, Finland; University of Iowa, Iowa City, Iowa, USA; Yale University, New Haven, CT, USA; University of Texas, Houston, TX, USA; St. Pauls Hospital, Vancouver, British Columbia, Canada; Nagoya City University, Nagoya, Japan; University of North Carolina, Chapel Hill, NC, USA; University of Vienna, Vienna, Austria; University of Barcelona, Barcelona, Spain; Cornell Medical Center, New York, NY, USA; National Hospital, Oslo, Norway; Rockyview General Hospital, Calgary, Alberta, Canada EP - 714 TI - Antibody-Mediated Rejection Criteria – an Addition to the Banff '97 Classification of Renal Allograft Rejection VL - 3 SP - 708 KW - banff KW - transplant AU - Racusen, Lorraine AU - Colvin, Robert AU - Solez, Kim AU - Mihatsch, Michael AU - Halloran, Philip AU - Campbell, Patricia AU - Cecka, Michael AU - Cosyns, Jean-Pierre AU - Demetris, Anthony AU - Fishbein, Michael AU - Fogo, Agnes AU - Furness, Peter AU - Gibson, Ian AU - Glotz, Denis AU - Hayry, Pekka AU - Hunsickern, Lawrence AU - Kashgarian, Michael AU - Kerman, Ronald AU - Magil, Alex AU - Montgomery, Robert AU - Morozumi, Kunio AU - Nickeleit, Volker AU - Randhawa, Parmjeet AU - Regele, Heinz AU - Seron, Daniel AU - Seshan, Surya AU - Sund, Stale AU - Trpkov, Kiril PY - 2003/// UR - http://dx.doi.org/10.1034/j.1600-6143.2003.00072.x ER -